Directorate General of Drug Administration proposed The National Drug Policy 2016 for:

• Availability to efficacious, safe and quality drugs
• Rational and safe use of drugs;
• Drug registration
• Registration for import
• Production of drugs and raw materials
• Prevention of production, sale & distribution of fake, adulterated, substandard drugs
• Drug selection, quantity fixation. Drug procurement, storage and distribution processes
• Control of drug advertising and promotion
• New technology and technical knowledge transfer in Country
• Joint collaborative research and development of drugs
• Effective Monitoring of Pharmacovigilance or Adverse Drug Reactions (ADR)
• Incentives for drug export

Products covered: Medicine and pharmaceutical products

HS code: 30

Proposed date of adoption: 17-03-2017

Proposed date of entry into force: 17-03-2017

Final date for comments: NA

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures , so that these can be taken up suitably.